Loading...

KalVista Pharmaceuticals, Inc.

KALV•NASDAQ
Healthcare
Biotechnology
$26.67
$7.43(38.62%)
U.S. Market opens in 11h 24m

KalVista Pharmaceuticals, Inc. (KALV) Stock Overview

Explore KalVista Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.4B
P/E Ratio-8.07
EPS (TTM)$-3.94
ROE-4.44%
Fundamental Analysis

AI Price Forecasts

1 Month$15.58
3 Months$19.51
1 Year Target$15.28

KALV Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of KalVista Pharmaceuticals, Inc. (KALV) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 75.53, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $15.28.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -8.07 and a market capitalization of 1.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
38.62%
5-Day Change
36.35%
1-Month Change
37.97%
3-Month Change
70.42%
6-Month Change
143.34%
Year-to-Date (YTD) Change
65.14%
1-Year Change
103.90%
3-Year Change
200.68%
5-Year Change
5.71%
All-Time (Max) Change
-65.74%

Contact Information

https://www.kalvista.com
857 999 0075
55 Cambridge Parkway, Cambridge, MA, 02142

Company Facts

150 Employees
IPO DateApr 9, 2015
CountryUS
Actively Trading

Frequently Asked Questions